MB07811

· Ligand Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MB07811, covering 2011-08-12 to 2011-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of MB07811 in Subjects With Hypercholesterolemia [Phase 2]